These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38315668)

  • 21. Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.
    Lee MC; Chang H; Sun FJ; Wu AY; Lu CH; Lee CM
    Am J Trop Med Hyg; 2022 Aug; 107(2):467-473. PubMed ID: 35895586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Filling the gaps in the global prevalence map of clinical antimicrobial resistance.
    Oldenkamp R; Schultsz C; Mancini E; Cappuccio A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33372157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals.
    Daoud Z; Salem-Sokhn E; Dahdouh E; Irani J; Matar GM; Doron S
    J Glob Antimicrob Resist; 2017 Dec; 11():45-51. PubMed ID: 28756026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Determinants of Resistance to Extended-Spectrum Cephalosporin and Fluoroquinolone in Escherichia coli Isolated from Diseased Pigs in the United States.
    Hayer SS; Lim S; Hong S; Elnekave E; Johnson T; Rovira A; Vannucci F; Clayton JB; Perez A; Alvarez J
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.
    Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P
    Crit Care; 2010; 14(3):R113. PubMed ID: 20546564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal association between antibiotic use and resistance in
    Ryu S; Klein EY; Chun BC
    Antimicrob Resist Infect Control; 2018; 7():83. PubMed ID: 30026941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic Consumption in Hospitals and Resistance Rate of
    Mijović G; Čizmović L; Vuković MN; Stamatović S; Lopičić M
    Acta Clin Croat; 2020 Sep; 59(3):469-479. PubMed ID: 34177057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic utility and susceptibility changes of multidrug-resistant
    Veličković-Radovanović R; Stefanović N; Damnjanović I; Kocić B; Mladenović-Antić S; Dinić M; Petrović J; Mitić R; Catić-Đorđević A
    Eur J Hosp Pharm; 2022 Mar; 29(2):84-89. PubMed ID: 34907033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
    Livermore DM; Hope R; Reynolds R; Blackburn R; Johnson AP; Woodford N
    J Antimicrob Chemother; 2013 Nov; 68(11):2667-74. PubMed ID: 23766490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1495-1502. PubMed ID: 32221726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Econometric ARIMA methodology to elucidate the evolution of trends in nosocomial antimicrobial resistance rates in the European Union.
    Ortega-Huedo R; Cuesta M; Hoefer A; Gonzalez-Zorn B
    Int J Antimicrob Agents; 2020 Jan; 55(1):105800. PubMed ID: 31521811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis.
    Collignon P; Beggs JJ; Walsh TR; Gandra S; Laxminarayan R
    Lancet Planet Health; 2018 Sep; 2(9):e398-e405. PubMed ID: 30177008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing Antimicrobial Resistance in World Health Organization Eastern Mediterranean Region, 2017-2019.
    Talaat M; Zayed B; Tolba S; Abdou E; Gomaa M; Itani D; Hutin Y; Hajjeh R
    Emerg Infect Dis; 2022 Apr; 28(4):717-724. PubMed ID: 35318915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    BMC Infect Dis; 2020 Apr; 20(1):269. PubMed ID: 32264851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of the Resistance Mechanisms for
    Zahari NIN; Engku Abd Rahman ENS; Irekeola AA; Ahmed N; Rabaan AA; Alotaibi J; Alqahtani SA; Halawi MY; Alamri IA; Almogbel MS; Alfaraj AH; Ibrahim FA; Almaghaslah M; Alissa M; Yean CY
    Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003976
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.
    Rice LB
    Mayo Clin Proc; 2012 Feb; 87(2):198-208. PubMed ID: 22305032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic Review on the Occurrence of Antimicrobial-Resistant
    Islam MS; Hossain MJ; Sobur MA; Punom SA; Rahman AMMT; Rahman MT
    Biomed Res Int; 2023; 2023():2425564. PubMed ID: 36778056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial consumption and bacterial resistance pattern in patients admitted in I.C.U at a tertiary care center.
    Saxena S; Priyadarshi M; Saxena A; Singh R
    J Infect Public Health; 2019; 12(5):695-699. PubMed ID: 31000490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E. coli, K. pneumoniae and K. oxytoca community-acquired infections susceptibility to cephalosporins and other antimicrobials in Lebanon.
    Moghnieh RA; Musharrafieh UM; Husni RN; Abboud E; Haidar M; Abboud E; Abou Shakra D
    J Med Liban; 2014; 62(2):107-12. PubMed ID: 25011373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.